i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective
-
Published Date:
Aug 17 2013
-
Publisher's site:
-
Source:Support Care Cancer. 21(12):3461-3469.
-
Details:
-
Alternative Title:Support Care Cancer
-
Personal Author:
-
Description:Purpose Informal care plays an important role in the overall care for people with cancer. This study estimates lost productivity and informal caregiving and associated costs among partner caregivers of localized prostate cancer patients within 1 year after diagnosis. Methods We applied data from the Family and Cancer Therapy Selection study, a three-wave self-administered survey among patients diagnosed with localized prostate cancer and their partner caregivers in multiple clinics in the USA. Time spent was measured by the sum of working hours lost, informal caregiving hours performed, and hours spent on household chores. The national median income for women 55 years or older was used to calculate costs associated with the time spent using the opportunity cost method. Descriptive and bivariate analyses were conducted. Results The average working hours decreased from 14.0 h/week (SD=17.6) to 10.9 h/week (SD=15.9), without a significant change in responsibility/intensity at work. The mean annual time spent on informal caregiving and household chores was 65.9 h/year (SD=172.4) and 76.2 h/year (SD=193.3), respectively. The mean annual economic burden among partner caregivers was US$6,063 (range US$571–US$47,105) in 2009 dollars accounted for by a mean of 276.2 h (range 26–2,146) in the study sample. The time spent on informal caregiving and household chores varied by patient and caregiver characteristics. Conclusions Pilot estimates on non-medical economic burden among partner caregivers (spouses) during the initial phase of the treatment provide important information for comprehensive estimation of disease burden and can be used in cost-effectiveness analyses of prostate cancer interventions.
-
Subject:
-
Pubmed ID:23955026
-
Pubmed Central ID:PMC4535430
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/plain image/gif image/jpeg image/gif image/jpeg
No Related Documents.